The aim of the present systematic review and meta-analysis was to expand examination of the effects of GLP-1RA in addition to insulin treatment in patients with T1D with regard to glycemic control, body weight, TID, time-in-range (TIR), and incidence of severe hypoglycemia. The gene discussed is INS; the disease is type 1 diabetes mellitus.